SMS Lifesciences India Limited
SMS Lifesciences India Limited Fundamental Analysis
SMS Lifesciences India Limited (SMSLIFE.NS) shows weak financial fundamentals with a PE ratio of 18.97, profit margin of 5.71%, and ROE of 9.70%. The company generates $3.5B in annual revenue with weak year-over-year growth of -3.04%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 47.8/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze SMSLIFE.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakSMSLIFE.NS struggles to generate sufficient returns from assets.
Valuation Score
ModerateSMSLIFE.NS shows balanced valuation metrics.
Growth Score
WeakSMSLIFE.NS faces weak or negative growth trends.
Financial Health Score
ExcellentSMSLIFE.NS maintains a strong and stable balance sheet.
Profitability Score
WeakSMSLIFE.NS struggles to sustain strong margins.
Key Financial Metrics
Is SMSLIFE.NS Expensive or Cheap?
P/E Ratio
SMSLIFE.NS trades at 18.97 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, SMSLIFE.NS's PEG of 3.08 indicates potential overvaluation.
Price to Book
The market values SMS Lifesciences India Limited at 1.82 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 6.11 times EBITDA. This is generally considered low.
How Well Does SMSLIFE.NS Make Money?
Net Profit Margin
For every $100 in sales, SMS Lifesciences India Limited keeps $5.71 as profit after all expenses.
Operating Margin
Core operations generate 9.01 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $9.70 in profit for every $100 of shareholder equity.
ROA
SMS Lifesciences India Limited generates $5.04 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
SMS Lifesciences India Limited generates limited operating cash flow of $300.13M, signaling weaker underlying cash strength.
Free Cash Flow
SMS Lifesciences India Limited produces free cash flow of $185.73M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $61.43 in free cash annually.
FCF Yield
SMSLIFE.NS converts 4.93% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
18.97
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
3.08
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.82
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.08
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.34
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.06
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.10
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
0.12
vs 25 benchmark
How SMSLIFE.NS Stacks Against Its Sector Peers
| Metric | SMSLIFE.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 18.97 | 28.45 | Better (Cheaper) |
| ROE | 9.70% | 763.00% | Weak |
| Net Margin | 5.71% | -45265.00% (disorted) | Weak |
| Debt/Equity | 0.34 | 0.34 | Neutral |
| Current Ratio | 1.06 | 2795.60 | Neutral |
| ROA | 5.04% | -16588.00% (disorted) | Weak |
SMSLIFE.NS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews SMS Lifesciences India Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-18.02%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
-49.05%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
-18.96%
Industry Style: Defensive, Growth, Innovation
Declining